As previously announced Lars Söderqvist has been acting as company restructuring trustee (Sw. "företagsrekonstruktör"), although only for the past 2 weeks, where he has been involved in identifying and negotiating possible financing options. The Company sees continuity as a means of avoiding delay and additional costs and therefore regards it as in creditors' best interests for Lars Söderqvist to be appointed as bankruptcy trustee.

Even during the bankruptcy process, Nectarine Health will continue its efforts to restructure the business and complete ongoing discussions, in order to preserve value and optimize returns for the Company's creditors (including Brighter).

For more information, please contact:
Investor Relations
IR@brighter.se

Certified Adviser
Brighter's Certified Adviser is Mangold Fondkommission AB,

About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

For more information, please visit our website at www.brighter.se

This information is information that Brighter AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 12:20 CEST on October 17 2022.